215 related articles for article (PubMed ID: 2924081)
1. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
Giles H; Leff P; Bolofo ML; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
[TBL] [Abstract][Full Text] [Related]
2. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
Trist DG; Collins BA; Wood J; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
[TBL] [Abstract][Full Text] [Related]
3. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
Hamid-Bloomfield S; Payne AN; Petrovic AA; Whittle BJ
Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
Hamid-Bloomfield S; Whittle BJ
Br J Pharmacol; 1989 Feb; 96(2):307-12. PubMed ID: 2647205
[TBL] [Abstract][Full Text] [Related]
5. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
Rangachari PK; Betti PA; Prior ET; Roberts LJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146
[TBL] [Abstract][Full Text] [Related]
6. AH6809, a prostaglandin DP-receptor blocking drug on human platelets.
Keery RJ; Lumley P
Br J Pharmacol; 1988 Jul; 94(3):745-54. PubMed ID: 2460179
[TBL] [Abstract][Full Text] [Related]
7. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
Lydford SJ; McKechnie KC; Leff P
Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
[TBL] [Abstract][Full Text] [Related]
8. Further studies on ocular responses to DP receptor stimulation.
Woodward DF; Spada CS; Hawley SB; Williams LS; Protzman CE; Nieves AL
Eur J Pharmacol; 1993 Jan; 230(3):327-33. PubMed ID: 8440310
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
Lydford SJ; McKechnie K
Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of the prostanoid DP receptor in human myometrium.
Fernandes B; Crankshaw D
Eur J Pharmacol; 1995 Sep; 283(1-3):73-81. PubMed ID: 7498323
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
Hamid-Bloomfield S; Whittle BJ
Br J Pharmacol; 1986 Aug; 88(4):931-6. PubMed ID: 3017497
[TBL] [Abstract][Full Text] [Related]
12. Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl- secretion in dog tracheal epithelium.
Liu YJ; Jackson DM; Blackham A; Leff P
Eur J Pharmacol; 1996 May; 304(1-3):117-22. PubMed ID: 8813592
[TBL] [Abstract][Full Text] [Related]
13. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells.
Chan CL; Jones RL; Lau HY
Br J Pharmacol; 2000 Feb; 129(3):589-97. PubMed ID: 10711359
[TBL] [Abstract][Full Text] [Related]
14. Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations.
Liu YJ; Jackson DM; Blackham A
Eur J Pharmacol; 1996 May; 303(3):187-92. PubMed ID: 8813566
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.
Giles H; Bolofo ML; Lydford SJ; Martin GR
Br J Pharmacol; 1991 Oct; 104(2):541-9. PubMed ID: 1665742
[TBL] [Abstract][Full Text] [Related]
16. RS-61756-007: a potent and selective thromboxane receptor (TP) agonist.
Eglen RM; Whiting RL
J Pharm Pharmacol; 1989 May; 41(5):347-9. PubMed ID: 2569526
[TBL] [Abstract][Full Text] [Related]
17. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
Lumley P; White BP; Humphrey PP
Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
[TBL] [Abstract][Full Text] [Related]
18. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
19. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
Chen J; Woodward DF
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.
Senior J; Marshall K; Sangha R; Clayton JK
Br J Pharmacol; 1993 Feb; 108(2):501-6. PubMed ID: 8448599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
